Figure 3.
DAS28 remission rates for tocilizumab 8 mg/kg versus comparator in the international phase 3 program. Tocilizumab was statistically superior to all comparators for DAS28 remission.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.